Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Beta-blocker under-use in COPD patients.

Lim KP, Loughrey S, Musk M, Lavender M, Wrobel JP.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 17;12:3041-3046. doi: 10.2147/COPD.S144333. eCollection 2017.

2.

Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.

Kim MS, Lee JH, Kim EJ, Park DG, Park SJ, Park JJ, Shin MS, Yoo BS, Youn JC, Lee SE, Ihm SH, Jang SY, Jo SH, Cho JY, Cho HJ, Choi S, Choi JO, Han SW, Hwang KK, Jeon ES, Cho MC, Chae SC, Choi DJ.

Korean Circ J. 2017 Sep;47(5):555-643. doi: 10.4070/kcj.2017.0009. Epub 2017 Sep 18. Review.

3.

Current Drug Therapy in Chronic Heart Failure: the New Guidelines of the European Society of Cardiology (ESC).

Berliner D, Bauersachs J.

Korean Circ J. 2017 Sep;47(5):543-554. doi: 10.4070/kcj.2017.0030. Epub 2017 Aug 21. Review.

4.

Chronic heart failure.

Hopper I, Easton K.

Aust Prescr. 2017 Aug;40(4):128-136. doi: 10.18773/austprescr.2017.044. Epub 2017 Aug 1. Review. No abstract available.

5.

Mean Platelet Volume as a Predictor of Heart Failure-Related Hospitalizations in Stable Heart Failure Outpatients with Sinus Rhythm.

Kaya H, Kutay Yıldırımlı M, Kurt R, Beton O, Birhan Yilmaz M.

Acta Cardiol Sin. 2017 May;33(3):292-300.

6.

Heart failure, post-hospital mortality and renal function in Tanzania: A prospective cohort study.

Kingery JR, Yango M, Wajanga B, Kalokola F, Brejt J, Kataraihya J, Peck R.

Int J Cardiol. 2017 Sep 15;243:311-317. doi: 10.1016/j.ijcard.2017.05.025. Epub 2017 May 9.

PMID:
28522164
7.

Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure.

Nakanishi K, Di Tullio MR, Qian M, Thompson JLP, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GYH, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S; WARCEF Investigators.

Cerebrovasc Dis. 2017;44(1-2):43-50. doi: 10.1159/000474958. Epub 2017 Apr 19.

8.

The Real Role of β-Blockers in Daily Cardiovascular Therapy.

Dézsi CA, Szentes V.

Am J Cardiovasc Drugs. 2017 Mar 29. doi: 10.1007/s40256-017-0221-8. [Epub ahead of print] Review.

9.

One-Year Outcomes of Acute Decompensated Systolic Heart Failure in Taiwan: Lessons from TSOC-HFrEF Registry.

Chang HY, Wang CC, Wu YW, Chu PH, Wu CC, Hsu CH, Wen MS, Voon WC, Lin WS, Huang JL, Chen SM, Yang NI, Chang HC, Chang KC, Sung SH, Shyu KG, Lin JL, Mar GY, Chan KC, Kuo JY, Wang JH, Chen ZC, Tseng WK, Cherng WJ, Yin WH.

Acta Cardiol Sin. 2017 Mar;33(2):127-138.

10.

Impact of metoprolol treatment on mental status of chronic heart failure patients with neuropsychiatric disorders.

Liu X, Lou X, Cheng X, Meng Y.

Drug Des Devel Ther. 2017 Jan 25;11:305-312. doi: 10.2147/DDDT.S124497. eCollection 2017.

11.

Management Of Atrial Fibrillation In Patients With Heart Failure.

E Darby Md A.

J Atr Fibrillation. 2014 Aug 31;7(2):1105. doi: 10.4022/jafib.1105. eCollection 2014 Aug-Sep. Review.

12.

Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure.

Jujo K, Saito K, Ishida I, Furuki Y, Kim A, Suzuki Y, Sekiguchi H, Yamaguchi J, Ogawa H, Hagiwara N.

ESC Heart Fail. 2016 Sep;3(3):177-188. Epub 2016 Mar 31.

13.

Sacubitril/valsartan in heart failure: latest evidence and place in therapy.

Kaplinsky E.

Ther Adv Chronic Dis. 2016 Nov;7(6):278-290. Epub 2016 Oct 19. Review.

14.

Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus.

Bahtiyar G, Gutterman D, Lebovitz H.

Curr Diab Rep. 2016 Nov;16(11):116. Review.

15.

A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure.

Zhang X, Shen C, Zhai S, Liu Y, Yue WW, Han L.

Exp Ther Med. 2016 Oct;12(4):2489-2496. Epub 2016 Sep 5.

16.

Taxonomy of segmental myocardial systolic dysfunction.

McDiarmid AK, Pellicori P, Cleland JG, Plein S.

Eur Heart J. 2017 Apr 1;38(13):942-954. doi: 10.1093/eurheartj/ehw140. Review.

17.

New medications for heart failure.

Gordin JS, Fonarow GC.

Trends Cardiovasc Med. 2016 Aug;26(6):485-92. doi: 10.1016/j.tcm.2016.02.008. Epub 2016 Mar 3. Review.

18.

Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm.

Loudon BL, Noordali H, Gollop ND, Frenneaux MP, Madhani M.

Br J Pharmacol. 2016 Jun;173(12):1911-24. doi: 10.1111/bph.13480. Epub 2016 May 6. Review.

19.

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.

Tang CH, Wang CC, Chen TH, Hong CY, Sue YM.

J Am Heart Assoc. 2016 Jan 6;5(1). pii: e002584. doi: 10.1161/JAHA.115.002584.

20.

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature.

DiNicolantonio JJ, Fares H, Niazi AK, Chatterjee S, D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Lavie CJ, Bell DS, O'Keefe JH.

Open Heart. 2015 Mar 21;2(1):e000230. doi: 10.1136/openhrt-2014-000230. eCollection 2015. Review.

Supplemental Content

Support Center